Gallagher Duncan 4
4 · Health Catalyst, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst (HCAT) Director Gallagher Duncan Receives 7,562 RSUs
What Happened Gallagher Duncan, a director of Health Catalyst, acquired 7,562 restricted stock units (RSUs) on February 17, 2026. The transaction is reported as an award/grant (code A) at $0.00 per unit on the Form 4; a footnote states these RSUs were granted under the 2019 Plan and 100% vested on Feb 17, 2026, converting the RSUs into the right to receive one share per RSU.
Key Details
- Transaction date and type: 2026-02-17 — Grant/Award of 7,562 RSUs (code A) reported at $0.00.
- Shares owned after transaction: Not specified in the provided summary of the filing.
- Footnote: RSUs issued under the Issuer’s 2019 Stock Option and Incentive Plan; each RSU equals one contingent share and 100% vested on Feb 17, 2026 under the Non-Employee Director Compensation Policy.
- Filing timeliness: Form filed Feb 19, 2026 for a Feb 17 transaction — appears timely (not marked late).
Context RSUs are compensation awards that convert into shares when they vest; because these RSUs vested, the insider obtained the underlying share rights. This type of director compensation is routine and does not necessarily signal a buy/sell view by the insider. The filing does not show any tax withholding or immediate sale related to the award.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-17+7,562→ 132,023 total
Footnotes (1)
- [F1]Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on February 17, 2026.